Alexandria Real Estate Equities
ARE
#2397
Rank
HK$61.28 B
Marketcap
HK$351.91
Share price
0.35%
Change (1 day)
-16.56%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

EPS for Alexandria Real Estate Equities (ARE)

EPS in 2023 (TTM): HK$10.89

According to Alexandria Real Estate Equities 's latest financial reports the company's current EPS (TTM) is -HK$66.06. In 2022 the company made an earnings per share (EPS) of HK$24.56 a decrease over its 2021 EPS that were of HK$29.73.

EPS history for Alexandria Real Estate Equities from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$10.89-55.65%
2022HK$24.56-17.41%
2021HK$29.73-35.32%
2020HK$45.9789.03%
2019HK$24.32-12.68%
2018HK$27.85124.68%
2017HK$12.40-179%
2016-HK$15.69-221.95%
2015HK$12.8762.38%
2014HK$7.92-36.87%
2013HK$12.5546.79%
2012HK$8.55-36.63%
2011HK$13.49-20.74%
2010HK$17.02-21.66%
2009HK$21.73-3.48%
2008HK$22.528.3%
2007HK$20.7916.23%
2006HK$17.890.88%
2005HK$17.73-9.27%
2004HK$19.54-23.36%
2003HK$25.5081.56%
2002HK$14.047.19%
2001HK$13.10-7.22%
2000HK$14.1221.62%
1999HK$11.61-8.07%
1998HK$12.63-217.81%
1997-HK$10.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.57-108.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.35-466.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$136.35-306.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$24.32-63.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$46.21-169.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.46-153.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$155.42-335.27%๐Ÿ‡บ๐Ÿ‡ธ USA